Market Research Blog – Page 14604 – New Product Development

Pea Protein Market Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031

Increasing consumer interest in dietary protein has bolstered demand for pea protein globally. According to a Future Market Insights (FMI) report, the market is set to reach a valuation of US$ 3.2 Bn in 2021, growing at an exponential rate of over 14.2% through the end of 2031.

Consumers are focusing on plant-based proteins sources due growing interest in vegetarian and vegan diets, clean label trends, and the need to minimize allergens from animal-based products.

Millennial consumers are increasingly concerned about their health and nutrition, which has led to increased adoption of organic and natural food, free of additives, with non-GMO certifications. This trend is expected to increase demand for pea protein in the global market.

A growing millennial population is likely to create opportunities for food and beverage manufacturers. North America and Europe will continue to exhibit high demand for pea protein, while South Asia will emerge as a lucrative region for market players.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-697

The global rise in obesity and diabetes rate is also influencing consumers to change their dietary habits, creating a conducive environment for pea protein sales.

Companies are therefore focusing on labelling their products appropriately in accordance to strict regulatory guidelines. Organic food products, for example, are identified through their labels, which often certify their 100 purity.

Furthermore, the growing number of private label brands and increasing investments in promotional campaigns and marketing strategies for organic products evoke a sense of authenticity for product purchases.

The pea protein industry is influenced by growth in premium protein lines. Premium product sales are currently mainstream in Japan, and are increasingly distinguishing themselves from private label options. Premium ‘selected’ product versions are aimed at consumers who are willing to pay a higher price for high-quality ingredients.

Key Takeaways from the Pea Protein Market Study:

The U.S. pea protein market leads in North America and accounts for 82% in 2021. Rising awareness towards personal health from millennials aids growth.
Germany leads the Europe market, supported by the presence of key food processing units, accounting for nearly US$ 222 Mn in 2021.
Japan is emerging as a high potential market in East Asia, reflecting a 18% CAGR through 2031, driven by demand in the cosmetic and personal care sector.
Conventional pea protein holds a share of 90.8% of the global pea protein market in 2021, supported by easier access to raw materials.
Protein isolates, driven by high protein content accounted for a market share of 46.3% in 2021 of the global market.

Who is Winning?

Pea protein manufacturers are largely focusing on offering products through various online retailers to meet the needs of the vast global consumer base. Efforts towards complying with quality expectations for pea protein products are gaining traction in the industry.

Some of the leading companies offering pea protein products include Glanbia Plc., Roquette Frères, Cargill Inc., Kerry Group PLC, DuPont De Nemours Inc., The Scoular Company, Puris Proteins LLC, Burcon NutraScience Corporation, Cosucra Groupe Warcoing S.A., Bata Food, Shandong Jianyuan Group, Axiom Foods, Inc., The Green Lab LLC and others.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-697

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Edible Nuts Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2031

Consumers are increasingly inclining towards healthy and nutrient-rich food items to stay fit and stave off the risk of various diseases. Future Market Insights (FMI), in a new study finds this to be one of the chief drivers of the edible nuts market, which is forecast to surpass US$ 20.28 Bn by 2021. Growth will therefore be driven by consumers selecting snacks that are high in nutritive values.

Among different types of edible nuts, whole nuts are most famous due to their application in confectionery, bakery products, and other desserts. Edible nuts are also multi-nutritional ingredients consumed widely as snacks by consumers going to the gym and focused on body building. These factors are contributing to the rising number of food dishes made with edible nuts as an ingredient in the food service industry.

Digitalization has enabled rapid growth across diverse industries. With the rising usage of the internet besides the easiness of online transactions, many edible nuts manufacturers are choosing online platform for the promotion and selling of their products. Moreover, the majority of consumers prefer buying from online channels, which is encouraging manufacturers to mark their presence on these platforms. Other platforms have also emerged over recent periods like specialty stores and food service platforms.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1530

Key Takeaways from the Edible Nuts Market Study

Exhibiting Y-o-Y growth at nearly 6.9% in 2021, the edible nuts market will continue exhibiting strong growth through the forecast period
The U.S. has emerged as a key pocket for sales, accounting for over 88% of the North America market based on value in 2021
The demand from the U.K. will continue rising at a high pace. The U.K. is expected to register 10.8% Y-o-Y growth in 2021
Germany and France will remain other key markets for sale of edible nuts in the Europe
Japan and South Korea will emerge as bright spots for sale in East Asia

Who is winning?

Several leading manufacturers are concentrating on providing edible nuts at an optimum price, owing to their increasing demand among consumers. Different companies have implemented integrated production approach to delivering cost-effective products in the market to escalate their industry footprints and to upsurge their production capacity. Prominent players of edible nuts are endowing in research and development to produce organic, non-GMO products from edible nuts.

Various hotel chains and restaurants are also partnering directly with growers of edible nuts for sourcing of high-quality edible nuts to be used in their dishes.

A few of the leading players operating in the edible nuts market Sun-Maid Growers of California, Hines Nut Company, John B. Sanfilippo & Son, are Archer Daniels Midland Company, Mariani Nut Company, Select Harvests Limited, Olam International Ltd, Durak Findik, Grower Direct Nut Co. Ltd, Borges Agricultural & Industrial Nuts, The Wonderful Company LLC, Germack Pistachio Company, Diamond Foods, Inc., Blue Diamond Growers, Nichols Farms, Keenan Farms and other players.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1530

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Fluoropolymer Market Competitive Growth Strategies Based on Type, Applications, End User and Region

The global fluoropolymer market is anticipated to witness significant growth during the assessment period, starting from 2021 to 2031. Fluoropolymer plays a crucial role in several end-use industries including automotive, industrial processing & appliances, healthcare, electrical & electronics, construction and others. Industrial processing & application and electrical & electronics are driving the market growth.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-453

In the latest edition of the study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors fuelling the demand for Fluoropolymer. The report tracks the global sales of Fluoropolymer in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the rubber, plastics, automotive and construction in general, and Fluoropolymer in particular.

How the Historical and Future Outlook for Fluoropolymer Market will Match Up?

Fluoropolymer consumption is projected to grow by 1.7X during the forecast period. End-use segments are growing at a considerable rate since last few years, which is expected to experience significant growth in the near future.

In terms of regional classification of the market, East Asia and Europe are estimated to dominate at a global level and are expected to continue their dominance in the long run. The increasing consumption of fluoropolymer in the regions owing to rapidly increasing industrial infrastructure and favorable government initiatives will aid the overall expansion. Furthermore, increasing investments by regional governments for industrial development is expected to be one of the key driving factor for the global fluoropolymer market over the coming years.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-453

Leading manufacturers are expanding their production capacities to satisfy the demand created by end users. Leading manufacturers of fluoropolymer are strategically collaborating with end users especially industrial processing application for ensure long-term supply. According to FMI’s analysis, fluoropolymer sales to grow at 5.3% % CAGR between 2021 and 2031.

Fluoropolymer are used in pump, impellers, coating for heat exchangers, tanks, reaction vessels, autoclaves, container, flue duct expansion joints, diaphragms and among others for various end use application owing to its excellent mechanical properties, chemical resistance properties it preference over other polymers gain traction in the market.

The ongoing crisis on account of COVID-19 outbreak has impacted the global economy and industrial sector to a significant extent due to the disruption in the supply chain and reduce demand from the consumers. The same case has remain true for the case of Fluoropolymer, wherein reduce demand from many end use industries like automotive, has impacted the growth rate of the global Fluoropolymer market to a certain extent in the year 2020.

However, with initiatives taken by regional governments to revive the economic growth and to improve the performance of the industrial sector, will have a positive effect on the fluoropolymer sales prospects.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-453

Competitive Landscape

Introduction of new and innovative products, solutions and technologies for end-use industries, are expected to remain key focus of market players as they aim to gain competitive advantage. Tier-I companies are planning to venture into collaboration and acquisitions of accompanying businesses to further increase market presence. Companies operating in the market have been focusing on strategic tie-ups and product development to gain competitive advantage. Besides this, capacity expansion have been attracting ample resources of competitors.

For instance, in 2019, Dongyue Polymer announced its plans of launching a 20,000t fluoropolymer project to be located in Huantai County, Zibo City.

Some of the leading companies operating in the market are:

Mitsubishi Chemical Advanced Materials
AGC Chemicals Americas, Inc.
The Chemour Company
Honeywell International Inc.
Huntsman Corporation
Daikin Industries Limited
Dongyue Group Ltd.
Kureha Corporation
Poly Fluoro Ltd.
Amco Polymers
Solvay SA
Saint-Gobain Performance Plastics

Cassia Gum Market Perspective, Comprehensive Analysis, Growth and Forecast 2015-2025

According to the latest market report published by Future Market Insights (FMI) titled “Cassia Gum Market: Global Industry Analysis and Opportunity Assessment 2015-2025”, the cassia gum market was valued at US$ 10.1 Mn in 2015. It is expected to expand at a CAGR of 6.5% from 2015 to 2025, accounting for US$ 18.9 Mn by 2025.

Cassia gum made from the endosperm of Senna obtusifolia (also called Cassia obtusifolia or Cassia tora) is used as a food additive in food & beverage and manufacturing industry. Cassia gum is used as a gelling agent, stabilizer and thickener in food & beverage industry. Various technical applications of cassia gum are foam stabilization, emulsification, moisture retention and texture improvement. Key macroeconomic indicators directly influencing the global cassia gum consumption are growth in dairy ingredients market, confectionery market and growth in pet food market.

Till now cassia gum was preferred to be used as an alternative to gaur gum because of limited awareness and limited research and development activities. However with regulations approvals in various regions around the world and innovations in cassia gum formulations in dairy & confectionery products and pet food, cassia gum is expected to experience an upward trend during the forecast period. Companies are increasingly introducing Cassia in their new products, particularly in baby food, dairy and confectionery products such as chocolates, jellies, biscuits. Effective guidelines & standards are crucial across the cassia gum supply chain both for suppliers as well as international buyers. In countries such as India and China; which are the major producer and supplier of cassia gum, there is a near total absence of cassia gum specific rules and standards addressing both production and processing phase. This often hampers quality of Cassia Gum being imported by customers. Some other market restraints for cassia gum market are overdependence of Cassia Gum farmers on monsoon and availability of Alternatives at lower price points.

On the basis of food & beverage industry, the cassia gum market has been segmented into animal food (dog food, cat food, and animal feed), dairy & confectionery products, meat products and instant mixes. In animal food segment, dog food sub- segment is anticipated to account for a major share in the cassia gum market by 2025, in terms of value. The instant mixes segment is expected to witness the highest CAGR of 7.1% in terms of value, during the forecast period (2015-2025).

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-839

On the basis of manufacturing industry, the cassia gum market is segmented into cosmetics, pharmaceuticals, paper, textile, chemical processing and others (Mining, Oil & Gas). Demand for cassia gum in cosmetics sub-segment is expected to increase rapidly in the near future with over 48% share, in terms of value by 2025. Increase in demand of natural hair care formulations offering improved hair conditioning is also driving the usage of cassia gum in cosmetics sub-segment. Cassia hydroxypropyltrimonium chloride polymers are naturally derived from cassia gum which are for use in conditioning shampoo formulations. Cassia hydroxypropyltrimonium chloride polymers offer unique sensory experience, improved deposition and enhanced conditioning. Demand for pharmaceuticals sub-segment is expected to witness a CAGR of 6.3% during the forecast period.

The report provides detailed information about various trends driving each segment and offers insights and analysis about market trends in specific regions. The report also includes key market regulations regarding the application of cassia gum in aforementioned food & beverage and manufacturing industry applications. On the basis of region, the market is segmented into seven regions. North America is expected to dominate the market with 29.1% share by the end of 2015. APEJ and Western Europe markets are collectively estimated to account for 34.8% of the total cassia gum market value.

The report also delivers global cassia gum market opportunities, future outlook, trends, BPS analysis, market attractiveness analysis and competitive landscape of the key players in the cassia gum market. The key players in the report have been profiled on the basis of company overview, financials, operating segment share, product and service offerings and key developments.

Key players in the global cassia gum market include Agro Gums, Amba Gums & Feed Products, Avlast Hydrocolloids, Altrafine Gums, Premchem Gums Pvt. Ltd., Dwarkesh Industries, H.B. Gum Industries Private Limited, Fooding Group Limited, J D Gums and Chemicals.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-839

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Venous device market by Device Type, Treatment Type & End-Users 2021-2031 | Future Market Insights

Venous device market Forecast and CAGR

According to the latest research by Future Market Insights, Venous device market is set to experience 6.5% growth during the year 2021-2031. Venous devices are designed catheters to maintain the access to the venous system. There are two types of venous devices in the market that are peripheral venous device and central venous catheters. Peripheral venous devices are installed with the help of percutaneous vein puncture in hand or arms vein. They are 3 to 10 inches according to length. The tip present in the catheters does not permit penetration beyond the axillary lines, which further restricts infusates, which consist of drugs and vesicants that might cause irritation and also harm the peripheral veins.

Request For Table Of Content @ https://www.futuremarketinsights.com/toc/rep-gb-13881

What is driving Demand for Venous device market?

Various technological advancements taking place during the production of infusion pumps and catheters in Venous device market are like to uplift the market growth over the forecast period. Development and beneficial production taking place during the making of infusion pumps more accurate and precise has lowered down the risk of overdose and its related issues.

This has attributed the demand in the market as a basic treatment option for diabetic patient and chronic treatment. Furthermore, integration of these pumps is minimally encroaching which has uplifted their acceptance rate, thereby anticipating the market growth. For instance, presence of various gauge sizes for venous devices has also further augmented the market growth over the forecast period. Size variations helps in serving different purposes, which further enhances the accuracy of medication which further increases the safety level.

Technological Advancements Likely to Augment Veterinary Home Diagnostics Sales

Various technological advancements taking place during the production of infusion pumps and catheters in Vascular boot market are like to uplift the market growth over the forecast period. Development and beneficial production taking place during the making of infusion pumps more accurate and precise has lowered down the risk of overdose and its related issues.

U.S. and Canada Venous device market Outlook

U.S. and Canada are expected to have the highest share and therefore will dominate the Venous device market. This is due to increasing prevalence of various chronic diseases along with disorders such as cardiac problems, diabetes, multiple sclerosis due to this reason market is anticipated to grow at a significant rate in the upcoming years.

For instance, Abre venous self-expanding device which was innovated and approved by Food and drug administration (FDA) in year 2020.

Any Queries, Contact Us @ https://www.futuremarketinsights.com/askus/rep-gb-13881

Europe Demand Outlook for Veterinary Home Diagnostics

The European market for veterinary home diagnostics is estimated to grow at a considerable rate during the forecast period. The need for medication delivery technologies is anticipated to meet by a significant rise in the production od clinical drugs by various pharmaceutical companies. This has further resulted in huge product pipelines and increased returns on existing products, which further serves as the major factor driving the industry.

According to PR news, catheters represent as soft tube which is inserted into largest vein near a patient’s heart.

Who are the Key Manufacturers and Suppliers of Veterinary Home Diagnostics?

Some of the key players operating in the Venous device market are

Angio Dynamics
Smiths Medical
Cook Group Incorporated
Abbott Laboratories
Baxter International
C R Bard
Reinventing Venous Access
Becton Dickinson and Company
Boston Scientific Corporation
Teleflex Incorporated.

Manufacturers in the market focus on carrying out certain strategic activities such as acquisitions and merger, expansion, product launch, etc. For instance, • Abbott acquired CE mark approval for the FlexNav delivery system for the procedure of portico transcatheter aortic valve implantation system.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Venous device market Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Request For Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13881

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

Key Segment

By Device Type:

Ablation Devices
Surgical products
Venous Closure System

By Treatment Type:

Endovenous Ablation Powder
Sclerotherapy
Surgical Ligation
Stripping

By End Use:

Hospital pharmacies
Retail pharmacies
Mail order pharmacies
e-commerce

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East and Africa

Dimethylolpropionic Acid (DMPA) Market: Notable Developments & Geographical Outlook

Dimethylolpropionic acid is a crystalline compound that is increasingly gaining traction for its extensive use in the development of aqueous urethane dispersions, which are ideal for high gloss waterborne coating offerings with superior flexibility and free-flow characteristics. Dimethylolpropionic acid is also used in powder coatings as a modification agent in epoxy polyester compounds for improving flow properties, higher levels of gloss, and better impact resistance. Furthermore, DMPA is also used in the development of urethane elastomers for multi-substrate applications.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-339

The growing global demand for electrodeposition coatings particularly, arising from the metals production and processing sector is expected to positively influence market growth. Electro-deposition allows for low-cost production of coatings, while maintaining high performance standards, improving the functional properties of the material. Dimethylolpropionic acid is also widely used in electric appliances such as HVAC systems. Consequently, the use of associated coatings will drive growth over the forecast period.

ESOMAR-certified market analysis and consulting company Future Market Insights (FMI) delivers insights into key factors driving the dimethylolpropionic acid market in its latest report. Additionally, an evaluation of the effect of the COVID-19 pandemic on the dimethylolpropionic acid market in general, and an analysis of sales in 20+ high-growth markets and relevant end-use industries has been provided in the report.

For the past five years, from 2016 to 2020, the dimethylolpropionic acid market has displayed healthy growth with a CAGR of over 8%. Prominent manufacturers including Perstorp Specialty Chemicals AB, Henan Tianfu Chemical Co. Ltd., Jiangxi Nancheng Hongdu Chemical Technology Development Co., Ltd., have encouraged efforts towards portfolio expansion strategies, in addition to strategic collaborations and acquisitions in developed and developing countries.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-339

As per the Future Market Insights report, the covid-19 pandemic cut into the short-term rate of growth in the dimethylolpropionic acid industry. However, the market is expected to witness a steady recovery through 2021 with an estimated CAGR between 7% and 10%. Countries across the Asia Pacific excluding Japan region will remain major contributors to growth. Increasing awareness and rapid adoption of polyurethane dispersion processes in the United States will provide major impetus to developments of the market in the near future.

Dimethylolpropionic Acid Market – Competitive Landscape

Leading manufacturers in the moderately consolidated dimethylolpropionic acid market are focused increasingly on research and development efforts aimed towards portfolio expansion objectives, in addition to extensive efforts towards seeking strategic acquisitions and collaborations in the industry.

In September 2019, CPS Performance Materials announced the acquisition of GEO Specialty Chemicals, which will allow the company to expand its market portfolio, and special chemicals for personal care and nutrition applications.

In April 2021, CD Bioparticles introduced a series of dendrimers, including DMPA-G1-TMP-Azide, DMPA-G1-TMP-Acetylene, DMPA-G1-TMP-NHBOC, and DMPA-G1-TMP-Carboxyl for applications in coatings, theranostics adhesives, biosensors, and optics.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-339

Waters™ leading chromatography data software (CDS), Empower™, with the introduction of Metrohm Ion Chromatograph, for applications in universal software platform, aimed towards faster sample turnaround.

Future Market Insights has also analyzed the following players in the dimethylolpropionic acid market in its detailed report*:

Geo Specialty Chemicals Inc.
Perstorp Specialty Chemicals AB
Henan Tianfu Chemical Co. Ltd.
Jiangxi Nancheng Hongdu Chemical Technology Development Co. Ltd.
Shenzhen Vtolo Chemicals Co., Ltd.

Transplant Monitoring Kits Market Trends, Strong Application Scope, Key Players, Growth Overview and Forecast by 2031

According to the latest research by Future Market Insights, Transplant Monitoring Kits Market is expected to witness robust growth with 4-5% CAGR during the forecast period from 2021 to 2031.

The Transplant Monitoring Kits will show growth due to the rising organ transplants globally and an increased number of donors to support the recipients’ transplantation. Therefore, growth at a significantly high CAGR will be expected soon.

What is driving the Demand for Transplant Monitoring Kits?

The rising transplants globally are giving a major driving factor for the requirement of transplant monitoring kits. Among transplant recipients, non-adherence to immunosuppressive medications is a major cause of antibody-mediated rejection, which leads to graft loss.

Immunosuppressant non-adherence also contributes to the increased healthcare costs associated with acute rejection treatment, additional hospitalization, and kidney transplantation re-dialysis. Therefore, it is crucial to monitor post-transplantation who require long-term pharmacotherapy and prevent non-adherence.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13879

Previous studies have reported that approximately 14–36% of kidney transplant recipients are non-adherent to immunosuppressive medications. The immune system is inclined to attack foreign organisms introduced to the body, and the body interprets a new organ as foreign.

Also, there has been significant growth in stem cell transplants for treating chronic diseases which will drive the market.

Which factors are likely to augment the Growth of the Transplant Monitoring Kits Market?

According to a study, end-stage organ failure is estimated to affect more than six million people worldwide. Advancements in surgical techniques, immunosuppression, donor-recipient matching, and antimicrobial agents have all contributed to increasing patient success during transplant procedures.

Close monitoring of patients is essential after a transplant to ensure the body is not rejecting its new organ. The transplant patients usually receive therapeutic drugs post-transplant to help their bodies accept the new organ and remain healthy.

These therapeutic drugs require monitoring to make sure the patient is receiving the correct dosage for the greatest benefit without negative side effects or complications. As transplantation is the most favourable therapy for end-stage disease, the risk of rejection remains a constant concern.

Allograft rejection leads to a high risk of graft dysfunction, accompanied by a significantly higher probability of chronic failure and graft loss. This causes re-hospitalization and prolonged therapy or maybe death. Therefore it’s important to monitor the post-transplant.

Who are the Key Manufacturers and Suppliers of Transplant Monitoring Kits?

Some of the leading manufacturers and suppliers of Transplant Monitoring Kits include

CareDx Inc.
Thermo Fisher Scientific
QIAGEN
Hologic Inc.
Eurofins Scientific
JETA Molecular BV.
ELITech Group SAS
NateraInc.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13879

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Stress Tracking Devices Market Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031

According to the latest research by Future Market Insights, stress tracking devices market is set to experience positive growth during the year 2021-2031. The global stress tracking devices is witnessing demand every year as stress become apparent each year.

Stress Tracking Devices Market study by “Future Market Insights” provides details about the market dynamics affecting the market, Covid-19 Impact, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.

Get a Sample Copy of Report – https://www.futuremarketinsights.com/reports/sample/rep-gb-13877

This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market estimations considering all the parameters and market dynamics. Every crucial and decisive detail for the development and restriction of the market is mentioned in fine points with solutions and suggestions that may affect the market in near future. Segmentation of the market are studied specifically to give profound knowledge for supplementary market investments.

The report Stress Tracking Devices Market gives varied description about the segmentation of the market on the basis of segmented Dosage, Route of Administration and Application, and leads with a descriptive structure of the trends and restrictions of the various segments and sub segments. It also provides the market size and estimates a forecast from the year 2018 to 2028 with respect to major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the Stress Tracking Devices Market.

The report facilitates in determining and interpreting the key market players, portfolios with necessary information such as company profiles, components and services offered, financial information of past few years, key developments in past few years, that helps in constructing strategies to gain competitive advantage in the long run. The report also analyzes factors affecting Stress Tracking Devices Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend.

Leading Stress Tracking Devices Market Players:

Oura Health Oy.
WHOOP
NeuroSky
Garmin Ltd
Fitbit Inc.
Apple Inc.
SAMSUNG
Pebble Technology Corp.
Google Inc.
Xiaomi Technology Co. Ltd.
Jawbone and Nike.

Key Elements that the report acknowledges:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance

Request Table of Content for this Insight – https://www.futuremarketinsights.com/toc/rep-gb-13877

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Bioimpedance Devices Market size is projected to total US$ 715.1 Million by 2028 – Comprehensive Research Report by FMI

Sales in the global Bioimpedance Devices Market are slated to top US$ 492.1 Mn in 2022. Expanding at a healthy 6.4% CAGR, the market size is projected to total US$ 715.1 Mn by 2028.

Increasing cases of CKD diseases are expected to contribute to the growth of the Bioimpedance Devices Market throughout the forecast period. Chronic kidney disease (CKD) is a medical condition that can be characterized by gradual loss of kidney function over time. As per the National Kidney Foundation, Inc., 30 million American adults have Chronic Kidney Disease and millions of others are at high risk of developing CKD.

Attribute	Details
Bioimpedance Devices Market Estimated Size 2022	US$ 492.1 Mn
Bioimpedance Devices Market Value-based CAGR (2022-2028)	~6.4%
Bioimpedance Devices Market Size in Projected 2028	US$ 715.1 Mn

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-5563

The Glomerular filtration rate (GFR) is the best overall index for studying kidney function. Bioelectrical impedance or Bioimpedance is used for improved estimation of glomerular filtration rate in non-diabetic patients with chronic kidney disease and also to estimate muscle mass. Bioelectrical impedance analysis (BIA) can also be used to measure appendicular lean mass (ALM).

The performance of these equations that include ALM BIA to estimate renal inulin clearance (GFR INU) can be compared with demographic variables and further used for modifications in diet for renal disease (MDRD) treatment.

Widespread online marketing channels have tremendously increased the sale of portable as well as hand-held Bioimpedance devices in recent years. For Instance, a research study estimated that in 2015, approximately 70% of the population in the U.S. depended on online shopping portals for buying different items.

Vendors operating in the Bioimpedance devices market are focusing on promotional strategies and online marketing to ensure better access to their devices and increase sales. Devices offered online also help vendors cut on operational and distribution costs.

The online marketing channel also allows vendors to offer information about devices in their portfolio and gain access to both global and local markets. In addition, these online marketing websites provide a broad selection of high-quality Bioimpedance systems at more affordable costs.

For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-5563

Scope of the Report

Attribute	Details
Forecast Period	2013-2021
Historical Data Available for	2022-2028
Market Analysis	Units for Volume and US$ Mn for Value
Key Regions Covered	North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan, and the Middle East & Africa.
Key Countries Covered	United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.
Key Market Segments Covered	Product Type, Modality, End Users, and Region
Key Companies Profiled	• General Electric Company • Omron Corporation • Fresenius Medical Care • ImpediMed Limited • SELVAS AI Inc. • Tanita Corporation • RJL Systems, Inc. • Maltron International Ltd. • Bodystat Limited • SMT Medical GmbH

Majority of the manufacturers in the Bioimpedance Devices makers are focusing on developing products that are portable and affordable. The popularity of portable Bioimpedance devices is increasing due to its various advantages. For instance, Bioimpedance Devices are noninvasive, reasonable, safe and easy to operate.

These devices are light in weight and thus, are extensively used in home-based healthcare settings for monitoring health of the entire family. All these factors, cumulatively, are expected to drive the demand for portable Bioimpedance devices during the forecast period. Portable/ Hand-held Bioimpedance devices are also tremendously being opted by people for traveling purposes.

For instance, the demand for ImpediMed SFB7, which is a hand-held Bioimpedance device, is increasing as this device is easy to carry. Technological advancements to enhance the quality of Bioimpedance devices and increase patient compliance are also projected to drive the growth of the market over the forecast period.

Multiple-frequency Bioimpedance Devices are highly preferred because these devices can measure impedances in various frequencies. This provides a better and efficient estimation of fat free mass, total body water and intra and extra cellular water.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-5563

Single frequency Bioimpedance devices can calculate fat free mass and total body water but these devices are not capable of estimating intra and extra cellular body water. Increasing popularity and growing awareness about multiple-frequency Bioimpedance devices is expected to boost market growth for Bioimpedance devices over the forecast period.

FMI has segmented the global Bioimpedance Devices market by product type, modality and end user. The Bioimpedance Devices market, by product type, is segmented into Single-frequency Bioimpedance Devices and Multiple-frequency Bioimpedance Devices. By Modality, the Bioimpedance devices market is segmented into Wired Bioimpedance Devices and Wireless Bioimpedance Devices.

Bioimpedance Devices, by end users, are segmented into Hospitals, Specialty Clinics, Rehabilitation Centers and Others. Region-wise segmentation includes North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. The wired Bioimpedance devices segment in the Bioimpedance Devices market is expected to witness a significant growth during the forecast period.

The report tracks some of the key companies operating in the Bioimpedance Devices market, including General Electric Company, Omron Corporation, Fresenius Medical Care, ImpediMed Limited, SELVAS AI Inc., Tanita Corporation, RJL Systems, Inc., Maltron International Ltd., Bodystat Limited and SMT Medical GmbH.

Buy Now@ https://www.futuremarketinsights.com/checkout/5563

Explore FMI’s Extensive ongoing Coverage on Healthcare

EMG Biosensors Market – According to the latest research by Fact.MR, EMG biosensors market is set to experience steady growth during the year 2021-2031.

Interchangeable Biosimilars Market – According to the latest research by Future Market Insights, the interchangeable biosimilars market is set to experience 6% growth during the year 2021-2031.

Compounded Bioidentical Hormone Therapy Market – According to the latest research by Future Market Insights, Compounded Bioidentical Hormone Therapy market is expected to grow at a CAGR of 5.2% during the forecast period.

Bioprocess Containers & Fluid Transfer Solutions Market – According to the latest research by Future Market Insights, the bioprocess containers & fluid transfer solutions market is set to witness a 14.7% growth during the year 2021-2031.

Topical Bioadhesives Market – According to the latest research by Future Market Insights, Topical Bioadhesives Market is set to experience growth during the year 2021-2031. The demand for topical bioadhesives increasing due to vast applications in various industries segments.

Airlift Bioreactors Market – According to the latest research by Future Market Insights, the airlift bioreactor market is set to witness positive growth of CAGR 11% during 2021-2031.

Bioimpedance Spectroscopy Market – According to the latest research by Future Market Insights, Bioimpedance spectroscopy market is set to witness a 9.3% growth during the year 2021-2031.

Subcutaneous Biologics Market – Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology.

Bioartificial Renal Assist Devices Market – This Bioartificial Renal Assist Devices market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape.

Rocking Bioreactors Market – A bioreactor is a device in which a biological reaction using culture is carried on. This bioprocess using bioreactor helps in the growth of cells or tissues.

Drug-Induced Immune Hemolytic Anemia Market Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031

According to the latest research by FMI, Drug-Induced Immune Hemolytic Anemia market is set to witness a growth CAGR of 8.4% during the year 2021-2031. The drug-induced immune hemolytic anemia is a rare cause of anemia often associated with poor outcomes including organ failure and even death.

The development of drug-induced immune hemolytic anemia is principally due to antibody development. The drug-induced immune hemolytic anemia market is expected to grow at a moderate pace due to the development and discovery of new drugs and the rising application of pharmacovigilance for drug imputability. The most common agents for drug-induced immune hemolytic anemia are cephalosporin and penicillin.

What is Driving Demand for Drug-Induced Immune Hemolytic Anemia?

The number of drugs and their suggested mechanisms associated with drug-induced immune hemolytic anemia have witnessed a significant change over the past 4 decades in terms of number of implicated drugs. According to the American Society of Hematology, a reported number of 125 drugs are associated with drug-induced immune hemolytic anemia as per 2017 data of reviewed publications.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13809

The three groups of drugs identified as predominant were antimicrobials which accounted for 42% of the implicated drugs, anti-inflammatory (15%) and anti-neoplastics (11%). The advancements in clinical pharmacology and the increasing number of reviewed case-based studies on the cause and mechanisms of drug-induced immune hemolytic anemia have resulted as drivers in case identification and timely drug withdrawal and hence are set to increase the business growth.

Which factors are likely to augment growth of Drug-Induced Immune Hemolytic Anemia?

The clinical expression of drug-induced immune hemolytic anemia is generally mild, but it is also witnessed to develop into acute severe hemolytic anemia and even death. The increasing number in the reports of second and third generation cephalosporin which lead to clinical hemolysis are set to act as augmentative factors for the drug-induced immune hemolytic anemia.

U.S. and Canada Drug-Induced Immune Hemolytic Anemia Outlook

The principal cases of drug-induced immune hemolytic anemia are identified after post-operative conditions. The region of North America holds a significant share in the identification and measures for mitigation and improvement of patient health during this period and will continue to do so over the forecast period. This is facilitated by the presence of advanced healthcare infrastructure, robust pharmacovigilance programs and high participation of providers in clinical programs on drug-induced immune hemolytic anemia. The American Association of Blood Banks is an active moderator of drug-induced immune hemolytic anemia market.

Europe Demand Outlook for Drug-Induced Immune Hemolytic Anemia

The outlook for drug-induced immune hemolytic anemia in the European region is expected to show a moderate influence over the forecast period. This is associated with the development of appropriate clinical guidelines by British Society for Hematology and management of drug-induced immune hemolytic anemia in post-operative situations.

Who are the Key Manufacturers and Suppliers of Drug-Induced Immune Hemolytic Anemia?

The key companies operating in Drug-Induced Immune Hemolytic Anemia are

ARUP Laboratories
Cyprotex
Creative Biolabs
machaon diagnostics
F. Hoffmann-La Roche Ltd.
Baxter International Inc.
Pfizer Inc
Zydus Cadila
Amneal Pharmaceuticals Inc
Incyte Corp

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13809

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario